Learn how to get Free YouTube subscribers, views and likes
Get Free YouTube Subscribers, Views and Likes

Kidney Cancer CLEAR Trial biomarker analysis: Toni Choueiri MD | Dana-Farber Cancer Institute

Follow
Dana-Farber Cancer Institute

Biomarker analysis in the phase 3 CLEAR trial shows biomarkers don't impact the superiority of lenvatinib plus pembrolizumab versus sunitinib as a firstline therapy in patients diagnosed with advanced kidney cancer.
DanaFarber's Toni Choueiri, MD, presents at #ASCO24. Video published 6/7/2024

posted by zapletomuy